Olfat SHAKER, Amina ALNORY, Hoda GAD, Gehan HEGAZY

The association of vaspin rs2236242 and leptin rs7799039 polymorphism with metabolic syndrome in Egyptian women

Background/aim: Genetic predisposition is implicated in the etiology of metabolic syndrome. This study aimed to investigate the association of vaspin rs2236242 and leptin rs7799039 polymorphisms with their serum levels and with the risk of developing metabolic syndrome in Egyptian women. Materials and methods: This case control study included 100 Egyptian women with metabolic syndrome and 100 without metabolic syndrome. The genotypes of vaspin rs2236242 and leptin rs7799039 were detected by a methodology based on PCR-RFLP. Serum vaspin and leptin levels were determined by ELISA. Results: The metabolic syndrome group was associated with higher serum vaspin and leptin levels when compared to the nonmetabolic syndrome group. The AA genotype of leptin rs7799039 was associated with metabolic syndrome and with higher serum leptin levels, while the different genotypes of vaspin rs2236242 were not associated with metabolic syndrome or different serum vaspin levels. Conclusion: The AA genotype of leptin rs7799039 was associated with metabolic syndrome and higher serum leptin levels. Serum leptin and vaspin can be used as diagnostic markers of metabolic syndrome.

PDF

___

1. Alberti KGM, Zimmet P, Shaw J. The metabolic syndromea new worldwide definition. Lancet 2005; 366: 1059-1062.
2. Wannamethee SG, Shaper AG, Lennon L. Reasons for intentional weight loss, unintentional weight loss, and mortality in older men. Arch Intern Med 2005; 165: 1035-1040.
3. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, Kahn R. Waist circumference and cardiometabolic risk: a consensus statement from shaping Americas health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity 2007; 15: 1061-1067.
4. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. P Natl Acad Sci USA 2005; 102: 10610-10615.
5. Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Bioph Res Co 2006; 339: 430-436.
6. Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Inv Drug 2008; 17: 327-333.
7. Blüher M. Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 2012; 41: 176-182.
8. Kempf K, Rose B, Illig T, Rathmann W, Strassburger K, Thorand B, Meisinger C, Wichmann HE, Herder C, Vollmert C. Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: results from the MONICA/KORA studies. Exp Clin Endocr Diab 2010; 118: 184-189.
9. Fain J, Bahouth S, Madan A. TNFα release by the nonfat cells of human adipose tissue. Int J Obesity 2004; 28: 616-622.
10. Zha JM, Di WJ, Zhu T, Xie Y, Yu J, Liu J, Chen P, Ding G. Comparison of gene transcription between subcutaneous and visceral adipose tissue in Chinese adults. Endocr J 2009; 56: 935-944.
11. Chan JL, Heist K, DePaoli AM, Veldhuis J.D, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003; 111: 1409-1421.
12. Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight lossinduced changes in regional neural activity responses to visual food stimuli. J Clin Invest 2008; 118: 2583- 2591.
13. Otero M, Lago Ro, Lago F, Casanueva FF, Dieguez C, GómezReino JJ, Gualillo O. Leptin, from fat to inflammation: old questions and new insights. Febs Lett 2005; 579: 295-301.
14. Zimmet P, Alberti K, Serrano Ríos M. A new International Diabetes Federation (IDF) worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol (English Edition) 2005; 58: 1371-1375.
15. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
16. Hashemi M, Rezaei H, Eskandari-Nasab E, Zakeri Z, Taheri M. Association between chemerin rs17173608 and vaspin rs2236242 gene polymorphisms and the metabolic syndrome, a preliminary report. Gene 2012; 510: 113-117.
17. Mammes O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F. Association of the G‐2548A polymorphism in the 5′ region of the LEP gene with overweight. Ann Hum Genet 2000; 64: 391- 394.
18. Joy T, Lahiry P, Pollex RL, Hegele RA. Genetics of metabolic syndrome. Curr Diabetes Rep 2008; 8: 141-148.
19. Povel C, Boer J, Reiling E, Feskens E. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 2011; 12: 952-967.
20. Choi SH, Kwak SH, Lee Y, Moon MK, Lim S, Park YJ, Jang HC, Kim MS. Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol 2011; 75: 628-635.
21. Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, Broch M, Aguilar C, Olona M, Porras JA. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. Bmc Med Genet 2011; 12: 60.
22. Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 57: 372-377.
23. Suleymanoglu S, Tascilar E, Pirgon O, Tapan S, Meral C, Abaci A. Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pr 2009; 84: 325-328.
24. Zhuo Q, Wang Z, Fu P, Piao J, Tian Y, Xu J, Yang X. Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pr 2009; 84: 27-33.
25. Özçelik E, Uslu S, Kebapçı N, Kara M, Dokumacıoğlu A, Musmul A. Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome. Diabetes Metab Syndr 2010; 4: 13-17.
26. Esteghamati A, Noshad S, Khalilzadeh O, Morteza A, Nazeri A, Meysamie A, Esteghamati A, Nakhjavani M. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects. Arch Med Res 2011; 42: 244-251.
27. Chiu FH, Chuang CH, Li WC, Weng YM, Fann WC, Lo HY, Sun C, Wang SH. The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults. Cardiovasc Diabetol 2012; 11: 40.
28. Bienertova-Vasku J, Bienert P, Tomandl J, Forejt M, Vavrina M, Kudelkova J, Vasku A. No association of defined variability in leptin, leptin receptor, adiponectin, proopiomelanocortin and ghrelin gene with food preferences in the Czech population. Nutr Neurosci 2008; 11: 2-8.
29. Hinuy HM, Hirata MH, Forti N, Diament J, Sampaio MF, Armaganijan D, Salazar LA, Hirata RD. Leptin G-2548A promoter polymorphism is associated with increased plasma leptin and BMI in Brazilian women. Arq Bras Endocrinol Metabol 2008; 52: 611-616.
30. Yiannakouris N, Melistas L, Yannakoulia M, Mungal K, Mantzoros CS. The -2548G/A polymorphism in the human leptin gene promoter region is associated with plasma free leptin levels; interaction with adiposity and gender in healthy subjects. Hormones (Athens) 2003; 2: 229-236.
31. Ben Ali S, Kallel A, Ftouhi B, Sediri Y, Feki M, Slimane H, Jemaa R, Kaabachi N. Association of G-2548A LEP polymorphism with plasma leptin levels in Tunisian obese patients. Clin Biochem 2009; 42: 584-588.
32. Constantin A, Costache G, Sima AV, Glavce, CS, Vladica M, Popov DL. Leptin G-2548A and leptin receptor Q223R gene polymorphisms are not associated with obesity in Romanian subjects. Biochem Bioph Res Co 2010; 391: 282-286.
33. Riestra P, Garcia‐Anguita A, Viturro E, Schoppen S, De Oya M, Garcés C. Influence of the leptin G‐2548A polymorphism on leptin levels and anthropometric measurements in healthy Spanish adolescents. Ann Hum Genet 2010; 74: 335-339.
34. Hinuy HM, Hirata MH, Sampaio MF, Armaganijan D, Arazi SS, Salazar LA, Hirata RD. Relationship between variants of the leptin gene and obesity and metabolic biomarkers in Brazilian individuals. Arq Bras Endocrinol Metabol 2010; 54: 282-288.
35. Fourati M, Mnif M, Kharrat N, Charfi N, Kammoun M, Fendri N, Sessi S, Abid M, Rebai A, Fakhfakh F. Association between Leptin gene polymorphisms and plasma leptin level in 3 consanguineous families with obesity. Gene 2013; 527: 75-81.
36. Ma D, Feitosa MF, Wilk JB, Laramie JM, Yu K, LeiendeckerFoster C, Myers RH, Province MA, Borecki IB. Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension 2009; 53: 473-479.